Daxxify to treat glabellar lines
Drug Name: Daxxify Active Ingredient: daxibotulinumtoixnA-lanm Indications: To treat moderate-to-severe glabellar lines associated with corrugator and/or procerus muscle activity. Approval Date: 9/7/2022 Company: Revance Therapeutics, Inc Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761127s000lbl.pdf